On Monday, Shares of Can-Fite BioPharma Ltd. (NYSEMKT:CANF), skyrocketed 51.62% to $3.29.
Can-Fite BioPharma, declared favorable data from further analysis of its Phase II/III double-blind, placebo-controlled study designed to test the efficacy of CF101 in patients with moderate-to-severe plaque psoriasis.
The study comprised of 326 patients through 17 clinical centers in the U.S., Europe, and Israel with a duration of 32 weeks where the primary endpoint was after 12 weeks. On March 30, 2015, Can-Fite declared the study did not meet its primary endpoint of a statistically noteworthy improvement in the Psoriasis Area Severity Index (PASI) 75 score relative to placebo after 12 weeks of treatment. However, based on further analysis of the efficacy and safety results from the study as described below, Can-Fite intends to continue the development of CF101 for the treatment of psoriasis and has initiated work on the design of the next advanced–stage clinical trial protocol.
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases.
At the end of Monday’s trade, Shares of xG Technology, Inc. (NASDAQ:XGTI), jumped 8.59% to $0.23.
xG Technology, declared a contract with DirectView Holdings, Inc. (DIRV), to integrate its xMax private mobile broadband technology with DirectView’s recently-declared body-worn camera planned for commercial launch early in the third quarter of 2015. The planned integration will consolidate the private, secure, high-performance communications capabilities of xMax with the advanced features and functionality of DirectView’s body-worn camera.
With a number of recent high-profile law enforcement incidents bringing national attention to the need for the use of body-worn cameras by public safety and police officers, both companies see a rapidly increasing market for real-time video access to personnel in security related operations. The integrated product offering by the two companies will provide a wide array of cutting-edge features, counting high-capacity streaming video and imbedded fingerprint access. The initial target markets will comprise law enforcement, military, government, education and real estate security.
xG Technology, Inc. develops communications technologies for wireless networks worldwide. The company’s intellectual property is embedded in proprietary software algorithms designed to offer cognitive interference mitigation and spectrum access solutions to organizations in a various industries, counting national defense and rural broadband.
National Bank of Greece S.A. (NYSE:NBG), ended its last trade with 8.13% gain, and closed at $1.33, after Greece reorganized the team involved in its bailout discusssions with the country’s international creditors, the Wall Street Journal reports, adding that the decision could reduce the influence Greece’s finance minister Yanis Varoufakis has on the sluggish talks.
“There’s a perception that the current finance minister’s negotiating style hasn’t been conductive to reaching a deal, so there are some hopes that this will take the talks in a more constructive direction,” fixed income strategist Lyn Graham-Taylor of Rabobank told the Journal.
Greece’s decision comes just days after it faced raised pressure from the Eurozone finance chiefs to move along the talks in order to come to a new agreement before Greece’s current financing deal expires at the end of June.
Greece’s alternative foreign minister, Euclid Tsakalotos, will lead a new policy negotiating team, the Journal said, also noting that European stocks rallied after the Greek decision.
National Bank of Greece S.A., together with its auxiliaries, provides diversified financial services. The company is involved in retail and commercial banking, asset administration, investment banking, brokerage, and insurance activities.
Finally, InspireMD, Inc. (NYSEMKT:NSPR), closed at $0.28, with 5.92% gain.
InspireMD, declared it received approval to commercialize MGuard™ Prime with MicroNet technology in Brazil. The approval was granted by the Agencia Nacional de Vigilancia Sanitaria (ANVISA). The BRICCS (Brazil, Russia, India, China, South Africa and South Korea) coronary stents sector is estimated to reach $1billion by 2016, growing at an average compound annual rate of 9.6% in 2012 to 2018, according to Research and Markets.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
